• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN? EL ICD DR; Implantable Cardioverter Defibrillator (Non-Crt)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN? EL ICD DR; Implantable Cardioverter Defibrillator (Non-Crt) Back to Search Results
Model Number D152
Medical Device Problem Codes Over-Sensing (1438); Pacing Problem (1439); Failure to Convert Rhythm (1540); Defibrillation/Stimulation Problem (1573); Inappropriate/Inadequate Shock/Stimulation (1574)
Health Effect - Clinical Codes Ventricular Fibrillation (2130); Shock from Patient Lead(s) (3162)
Date of Event 07/23/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that this implantable cardioverter defibrillator (icd) delivered inappropriate anti-tachycardia pacing (atp) and five electric shocks due to sinus tachycardia.The rate started with a 1:1 rhythm with a high rhythm id (rid) match, then rid became negative which led to the inappropriate therapy.The atp accelerated the ventricular tachycardia (vt) into the ventricular fibrillation (vf) zone.The rhythm went from vf to vt several times during the five shocks.Therapy was exhausted and didn't convert the arrythmia.Also, it was noted there was intermittent atrial oversensing of ventricular signals.Technical services (ts) recommended reprogramming options.This icd remains in service.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
This product investigation is still in progress.This report will be updated when product investigation is complete.
 
Event or Problem Description
It was reported that this implantable cardioverter defibrillator (icd) delivered inappropriate anti-tachycardia pacing (atp) and five electric shocks due to sinus tachycardia.The rate started with a 1:1 rhythm with a high rhythm id (rid) match, then rid became negative which led to the inappropriate therapy.The atp accelerated the ventricular tachycardia (vt) into the ventricular fibrillation (vf) zone.The rhythm went from vf to vt several times during the five shocks.Therapy was exhausted and didn't convert the arrythmia.Also, it was noted there was intermittent atrial oversensing of ventricular signals.Technical services (ts) recommended reprogramming options.This icd remains in service.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
This product investigation is still in progress.This report will be updated when product investigation is complete.This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.A risk review was completed and confirmed that the event of rhythm acceleration was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of no problem detected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN? EL ICD DR
Common Device Name
Implantable Cardioverter Defibrillator (Non-Crt)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
Boston Scientific Corporation
cashel road
clonmel E91 T 862
EI   E91 T862
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
+1(651)582-6168
MDR Report Key50133105
Report Number2124215-2026-41772
Device Sequence Number5675159
Product Code LWS
UDI-Device Identifier00802526534324
UDI-Public(01)00802526534324(17)260403
Combination Product (Y/N)N
Initial Reporter StateID
Initial Reporter CountryUS
PMA/510(K) Number
P960040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/04/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date04/03/2026
Device Model NumberD152
Device Catalogue NumberD152
Device Lot Number671920
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/23/2026
Initial Report FDA Received Date08/04/2026
Date Device Manufactured04/12/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Hospitalization;
Patient Age55 YR
Patient SexMale
-
-